We have previously shown that proteins associated with type I/II interferon responses (e.g., interferon gamma-inducible protein 10 [IP-10]) and complement cascade activation were elevated early during progression, up to 12 months before TB diagnosis, and are likely biomarkers of early incipient disease [10]. Here, CXCL10 is linked to tuberculosis.